|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
Actavis India
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:businessModel
|
generic_and_specialty_pharmaceuticals
|
|
gptkbp:certifications
|
gptkb:ISO_9001
gptkb:WHO_GMP
|
|
gptkbp:clinicalTrials
|
ongoing
conducted in-house
|
|
gptkbp:community_engagement
|
active
|
|
gptkbp:employees
|
over 10,000
|
|
gptkbp:exportedTo
|
to over 70 countries
|
|
gptkbp:financialPerformance
|
growing
|
|
gptkbp:founded
|
1977
|
|
gptkbp:founder
|
gptkb:Bhavin_S._Mehta
|
|
gptkbp:future_plans
|
innovation
sustainability
expansion
global outreach
|
|
gptkbp:global_presence
|
strong
|
|
gptkbp:headquarters
|
Ahmedabad,_India
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Intas Biopharmaceuticals Ltd.
|
|
gptkbp:investmentFocus
|
in research and development
in biotechnology
|
|
gptkbp:market
|
global
significant_in_India
|
|
gptkbp:partnerships
|
various international companies
with research institutions
|
|
gptkbp:productionLocation
|
multiple locations
|
|
gptkbp:productLine
|
diverse
|
|
gptkbp:products
|
biopharmaceuticals
generic pharmaceuticals
|
|
gptkbp:regulatoryCompliance
|
multiple countries
|
|
gptkbp:research_areas
|
diabetes
cardiology
neurology
oncology
infectious diseases
|
|
gptkbp:researchAndDevelopment
|
strong focus
|
|
gptkbp:revenue
|
over $1 billion
|
|
gptkbp:social_responsibility
|
active programs
|
|
gptkbp:subsidiary
|
gptkb:Intas_Pharma_(Germany)_GmbH
gptkb:Intas_Pharma_Ltd.
gptkb:Intas_Pharmaceuticals_Ltd.
gptkb:Intas_Pharma_(UK)_Ltd.
Intas Biopharmaceuticals USA, Inc.
|
|
gptkbp:sustainability_initiatives
|
implemented
|
|
gptkbp:website
|
www.intaspharma.com
|